Harte Hanks Reports Third Quarter Results LONDON, UNITED

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Harte Hanks Reports Third Quarter Results

LONDON, UNITED KINGDOM--(Marketwired - Oct 30, 2014) - Harte Hanks ( NYSE : HHS ), a leading marketing services organization that partners with top brands to establish deeper relationships with their customers and prospects, today announced financial results for the third quarter ended September 30, 2014.

Third quarter 2014 revenues of $134.1 million were relatively consistent with the $135.0 million of revenues in the same quarter last year. 

  • Customer Interaction revenues were $121.1 million compared to $121.3 million in the same quarter last year. Within Customer Interaction, our Financial Services vertical grew from increased credit card solicitation and home equity loan generation activity. In addition, we witnessed growth in our Technology, Auto and Consumer Brands, and Select market verticals largely from expansion of marketing programs with existing customers and the addition of several new customers. These increases were offset by a decrease in revenues in our Retail vertical as the result of expense reduction efforts from a couple of large retailers.
  • Trillium Software revenues declined 4.3% principally driven by decreased software license revenues. Maintenance and professional service revenues slightly decreased compared to the third quarter last year.

Operating income for the quarter was $10.6 million compared to $8.4 million for the same quarter last year. Third quarter 2013 results included a $2.8 million impairment charge related to the Aberdeen trade name.

  • Operating income for Customer Interaction was $7.6 million compared to $5.6 million ($8.3 million after adjusting for the previously mentioned 2013 impairment charge). 
  • Trillium Software operating income was $3.3 million compared to $3.9 million in the same period last year. This decrease was due primarily to the timing in software license revenues, as most of our costs in this business are fixed.
  • Severance charges increased $2.0 million over the same quarter last year as management aligned expenses with revenues through headcount reductions.

Third quarter 2014 diluted earnings per share from continuing operations were $0.10 compared to $0.07 for the same quarter in 2013. Third quarter 2013 diluted earnings per share from continuing operations were $0.10 excluding the impairment charge that quarter.

Capital expenditures for the quarter were $2.3 million compared to $3.6 million in the prior year's third quarter. This reduction is representative of management's continued efforts to prudently manage cash flows.

The following table presents financial highlights of the company's operations for the third quarter of 2014 and 2013, respectively. More detailed financial results are attached.

RESULTS FROM CONTINUING OPERATIONS (unaudited)

(In thousands, except per share amounts) Three Months Ended Sept. 30,
  2014   2013   % Change
Operating revenues $ 134,121   $ 134,973   -0.6%
Operating income 10,540   8,360   26.1%
Income from continuing operations 6,420   4,451   44.2%
Diluted earnings per share from continuing operations  0.10    0.07    42.9%
Diluted shares (weighted average common and common equivalent shares outstanding)  62,585    62,994    -0.7%

Commenting on the third quarter performance, Chief Executive Officer Robert Philpott said,  "There is much we can be pleased with in our latest performance. We continued to focus our efforts on revenue growth. Over the last nine months we have secured a stable base of revenues relative to the prior year despite a marginal decline in the third quarter. More importantly, we have recently secured some significant new business wins in both the U.S. and U.K. These are expected to benefit our revenue performance in subsequent quarters. For example, our sales team in the U.S. secured the largest new client opportunity for Harte Hanks since 2011 -- a multi-year contract in the financial services sector we project will drive over $20 million during its term. Our Agency business in the U.K. also excelled in its sales performance, and was appointed agency of record for a global telecommunications provider -- an engagement which should generate over $2 million of new revenues in the next 12 months. This engagement represents our U.K. Agency's largest new business win since 2010. It is incredibly heartening to report these large recent wins which are endorsements of our strategy to offer a broader, integrated customer engagement solution to clients.

"We have also made a great deal of progress on the realignment of our cost base in the past three months. We report this quarter an increase of $2 million in severance costs which reflects aggressive management of our largest cost item (people) in our business. Some of you may also have seen reports this week that indicate we are continuing to take further action on our labor costs in the fourth quarter. Along with these actions, we are reducing our geographic footprint, and over the past few months we have announced the consolidation of multiple office locations in California, Maryland, Texas and Pennsylvania, and closed a location in Ohio. We will continue to actively challenge our major cost categories for the foreseeable future, while still investing in our growth initiatives. The benefit from these actions began to accrue in our third quarter and will accelerate into the fourth quarter. This will allow us to enter 2015 with a cost base which is more closely aligned with our stabilizing revenue performance."

The company will host a conference call on October 30, 2014, at 9:00 a.m. Eastern Time to discuss the results. Investors and interested parties may participate in the call by dialing (888) 218-8176 for domestic callers and (913) 312-0398 for international callers and referring to Conference ID 5622076. To access an audio webcast, please go to the link within the Harte Hanks website located on the Investors section of the website, http://HarteHanks.com . A replay will be available shortly after the call through November 6, 2014 at (888) 203-1112 for domestic callers and (719) 457-0820 for international callers, Conference ID 5622076. 

About Harte Hanks:

Harte Hanks is one of the world's leading, insight-driven multi-channel marketing organizations, delivering impactful business results for some of the world's best-known brands. Through strategic agencies and our core marketing services, we develop integrated solutions that connect brands with prospects and customers, moving them beyond awareness to transactions and brand loyalty. Visit the Harte Hanks website at http://HarteHanks.com or call (800) 456-9748.

Cautionary Note Regarding Forward-Looking Statements:

Our press release and related earnings conference call contain "forward-looking statements" within the meaning of U.S. federal securities laws. All such statements are qualified by this cautionary note, provided pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements other than historical facts are forward-looking and may be identified by words such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "seeks," "could," "intends," or words of similar meaning. These forward-looking statements are based on current information, expectations and estimates and involve risks, uncertainties, assumptions and other factors that are difficult to predict and that could cause actual results to vary materially from what is expressed in or indicated by the forward-looking statements. In that event, our business, financial condition, results of operations or liquidity could be materially adversely affected and investors in our securities could lose part or all of their investments. These risks, uncertainties, assumptions and other factors include: (a) local, national and international economic and business conditions, including (i) market conditions that may adversely impact advertising expenditures and (ii) the impact of economic uncertainty in the United States and elsewhere on the financial condition, marketing expenditures and activities of our clients and prospects; (b) the demand for our services by clients and prospective clients, including (i) the willingness of existing clients to maintain or increase their spending on products and services that are or remain profitable for us, and (ii) our ability to predict changes in client needs and preferences; (c) economic and other business factors that impact the industry verticals we serve, including competition and consolidation of current and prospective clients, vendors and partners in these verticals; (d) our ability to manage and timely adjust our capacity, workforce and cost structure to effectively serve our clients; (e) our ability to improve our processes and to provide new products and services in a timely and cost-effective manner though development, license or acquisition; (f) our ability to protect our data centers against security breaches and other interruptions and to protect sensitive personal information of our clients and their customers; (g) our ability to respond to increasing concern, regulation and legal action over consumer privacy issues, including changing requirements for collection, processing and use of information; (h) the impact of other regulations, including restrictions on unsolicited marketing communications and other consumer protection laws; (i) fluctuations in fuel prices, paper prices, postal rates and postal delivery schedules; (j) the number of shares, if any, that we may repurchase in connection with our repurchase program; (k) unanticipated developments regarding litigation or other contingent liabilities; and (l) other factors discussed from time to time in our filings with the Securities and Exchange Commission, including under "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2013. The forward-looking statements in this press release and our related earnings conference call are made only as of the date hereof and we undertake no obligation to update publicly any forward-looking statement, even if new information becomes available or other events occur in the future.

Supplemental Non-GAAP Financial Measures:

In this press release and our related earnings conference call, the company intends to provide investors with a better understanding of operating results and underlying trends to assess the company's performance and liquidity. The company evaluates its operating performance based on several measures, including the non-GAAP financial measures of (1) free cash flow, defined as net income, plus depreciation and amortization, plus stock-based compensation (tax-effected), plus goodwill and other intangibles impairment (tax-effected) less capital expenditures, all of the aforementioned are from continuing operations and (2) EBITDA, defined as net income before interest, taxes, goodwill and other intangibles impairment, depreciation, and amortization. The company believes that free cash flow and EBITDA are useful supplemental financial measures for investors because they facilitate investors' ability to evaluate the operational strength of the company's business. Free cash flow and EBITDA, however, are not calculated in accordance with GAAP and they should not be considered substitutes for net income as an indicator of operating performance. A quantitative reconciliation of free cash flow and EBITDA to net income is found in the tables attached to this release.

As used herein, "Harte Hanks" refers to Harte-Hanks, Inc. and/or its applicable operating subsidiaries, as the context may require. Harte Hanks' logo and name are trademarks of Harte Hanks.

                         
Harte-Hanks, Inc.                    
Consolidated Statements of Operations (Unaudited)                  
                         
    Three months ended     Nine months ended  
    September 30,     September 30,  
In thousands, except per share data   2014     2013     2014     2013  
                                 
Operating revenues   $ 134,121     $ 134,973     $ 407,158     $ 407,430  
Operating expenses:                                
  Labor     67,026       68,341       207,943       205,601  
  Production and distribution     40,350       39,315       122,784       118,871  
  Impairment of Goodwill and Intangibles     -       2,750       -       2,750  
  Advertising, selling, general and administrative     12,528       12,258       39,118       38,243  
  Depreciation and amortization     3,677       3,949       11,207       11,788  
      123,581       126,613       381,052       377,253  
Operating income     10,540       8,360       26,106       30,177  
Other expenses (income):                                
  Interest expense     716       754       2,153       2,336  
  Interest income     (75 )     (25 )     (204 )     (76 )
  Other, net     (581 )     536       1,228       (600 )
      60       1,265       3,177       1,660  
Income from continuing operations before income taxes     10,480       7,095       22,929       28,517  
Income tax expense     4,060       2,644       9,027       10,810  
Income from continuing operations   $ 6,420     $ 4,451     $ 13,902     $ 17,707  
                                 
Gain from discontinued operations, net of income taxes     -       (12,624 )     -       (10,903 )
                                 
Net Income   $ 6,420     $ (8,173 )   $ 13,902     $ 6,804  
                                 
                                 
Basic earnings per common share                                
  Continuing operations   $ 0.10     $ 0.07     $ 0.22     $ 0.28  
  Discontinued operations     -       (0.20 )     -       (0.17 )
    Basic earnings per share   $ 0.10     $ (0.13 )   $ 0.22     $ 0.11  
                                 
  Weighted-average common shares outstanding     62,398       62,538       62,606       62,485  
                                 
Diluted earnings per common share                                
  Continuing operations   $ 0.10     $ 0.07     $ 0.22     $ 0.28  
  Discontinued operations     -       (0.20 )     -       (0.17 )
    Diluted earnings per share   $ 0.10     $ (0.13 )   $ 0.22     $ 0.11  
                                 
  Weighted-average common and common equivalent shares outstanding     62,585       62,994       62,818       62,808  
                                 
                                 
                                 
                                 
Balance Sheet Data (Unaudited)   September 30,     December 31,                  
In thousands   2014     2013                  
                                 
  Cash and cash equivalents   $ 67,234     $ 88,747                  
  Total debt   $ 87,281     $ 98,000                  
                                     
                                     
                                     
Harte-Hanks, Inc.                                    
Business Segment Information (Unaudited)                          
    Three months ended     Nine months ended  
    September 30,     September 30,  
In thousands   2014     2013     % Change     2014     2013     % Change  
                                             
OPERATING REVENUES:                                            
  Customer Interaction   $ 121,078     $ 121,338     -0.2 %   $ 367,134     $ 367,929     -0.2 %
  Trillium Software     13,043       13,635     -4.3 %     40,024       39,501     1.3 %
    Total operating revenues   $ 134,121     $ 134,973     -0.6 %   $ 407,158     $ 407,430     -0.1 %
                                             
OPERATING INCOME:                                            
  Customer Interaction   $ 7,601     $ 5,559     36.7 %   $ 18,742     $ 22,601     -17.1 %
  Trillium Software     3,318       3,931     -15.6 %     9,662       10,969     -11.9 %
  General corporate expense     (379 )     (1,130 )   66.5 %     (2,298 )     (3,393 )   32.3 %
    Total operating income   $ 10,540     $ 8,360     26.1 %   $ 26,106     $ 30,177     -13.5 %
      -       -             -       -        
DEPRECIATION AND AMORTIZATION:                                            
  Customer Interaction   $ 3,071     $ 3,380     -9.1 %   $ 9,618     $ 10,199     -5.7 %
  Trillium Software     600       565     6.2 %     1,571       1,578     -0.4 %
  General corporate expense     7       4     75.0 %     17       13     30.8 %
    Total depreciation and amortization   $ 3,678     $ 3,949     -6.9 %   $ 11,206     $ 11,790     -5.0 %
                                             
                                             
                                             
Harte-Hanks, Inc.                        
Harte Hanks Revenue Mix (Unaudited)                    
                         
                         
Vertical Markets - Percent of Customer Interaction's Revenue              
                         
    Three months ended     Nine months ended  
    September 30,     September 30,  
    2014     2013     2014     2013  
                         
Retail   26.6 %   30.7 %   26.7 %   30.4 %
Financial and Insurance Services   14.2 %   12.7 %   13.4 %   14.2 %
Technology   23.2 %   21.8 %   23.2 %   23.0 %
Healthcare and Pharmaceuticals   9.1 %   9.3 %   8.8 %   8.3 %
Auto and Consumer Brands   17.7 %   16.7 %   17.2 %   16.2 %
Other Select Markets   9.2 %   8.7 %   10.7 %   7.9 %
    100.0 %   100.0 %   100.0 %   100.0 %
                         
                         
                         
Vertical Markets - Percent of Trillium Software's Revenue              
                         
    Three months ended     Nine months ended  
    September 30,     September 30,  
    2014     2013     2014     2013  
                         
Retail   6.3 %   5.4 %   6.0 %   5.8 %
Financial and Insurance Services   30.4 %   26.6 %   28.0 %   25.5 %
Technology   22.3 %   29.5 %   22.4 %   29.0 %
Healthcare and Pharmaceuticals   5.7 %   7.3 %   6.2 %   6.6 %
Auto and Consumer Brands   22.9 %   20.7 %   25.6 %   22.4 %
Other Select Markets   12.3 %   10.6 %   11.9 %   10.8 %
    100.0 %   100.0 %   100.0 %   100.0 %
                         
                         
                         
Vertical Markets - Percent of Consolidated Revenue              
                         
    Three months ended     Nine months ended  
    September 30,     September 30,  
    2014     2013     2014     2013  
                         
Retail   24.6 %   28.2 %   24.7 %   28.0 %
Financial and Insurance Services   15.8 %   14.1 %   14.8 %   15.3 %
Technology   23.1 %   22.6 %   23.1 %   23.5 %
Healthcare and Pharmaceuticals   8.8 %   9.1 %   8.6 %   8.2 %
Auto and Consumer Brands   18.2 %   17.1 %   18.0 %   16.8 %
Other Select Markets   9.5 %   8.9 %   10.8 %   8.2 %
    100.0 %   100.0 %   100.0 %   100.0 %
                         
                         
                         
Harte-Hanks, Inc.                    
Reconciliation of Net Income to Free Cash Flow (Unaudited)  
             
    Three months ended     Nine months ended  
    September 30,     September 30,  
In thousands   2014   2013     2014   2013  
Income from continuing operations   $ 6,420   $ 4,451     $ 13,902   $ 17,707  
  Add: Intangible impairment (Note 1)           2,750             2,750  
  Add: After-tax stock-based compensation (Note 2)     600     725       1,978     2,640  
  Add: Depreciation and amortization     3,677     3,949       11,207     11,788  
  Less: Capital expenditures     2,251     3,591       7,089     12,760  
Free cash flow from continuing operations     8,446     8,284       19,998     22,125  
                             
Income/(Loss) from discont'd operations     -     (12,624 )     -     (10,903 )
  Add: After-tax stock-based compensation (Note 2)     -     (174 )     -     6  
  Add: Depreciation and amortization     -     853       -     2,592  
  Less: Capital expenditures     -     9       -     327  
Free cash flow from discontinued operations     -     (11,954 )     -     (8,632 )
                             
Total free cash flow   $ 8,446   $ (3,670 )   $ 19,998   $ 13,493  
                             
   
Note 1: Impairment of other intangibles was $2,750 with only non-cash tax impact for the three and nine months ended September 30, 2013.
   
Note 2: For continuing operations pre-tax stock-based compensation expense was $1,000 and $1,209 for the three months ended September 30, 2014 and 2013, respectively; and was $3,297 and $4,400 for the nine months ended September 30, 2014 and 2013, respectively. For discontinued operations, pre-tax stock-based compensation expense was ($290) for the three months ended September 30, 2014 and $6 for the nine months ended September 30, 2014.
   
   
                 
Reconciliation of Net Income to EBITDA from Continuing Operations (Unaudited)
         
    Three months ended   Nine months ended
    September 30,   September 30,
In thousands   2014   2013   2014   2013
Income from Continuing Operations   $ 6,420   $ 4,451   $ 13,902   $ 17,707
    Intangible Impairment           2,750           2,750
    Depreciation and amortization     3,677     3,949     11,207     11,788
    Interest expense, net and non-operating, net     60     1,265     3,177     1,660
    Income tax expense     4,060     2,644     9,027     10,810
EBITDA from Continuing Operations   $ 14,217   $ 15,059   $ 37,313   $ 44,715
                         
Scroll down for more posts ▼

Top 10 Most Recent News Articles

HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 190

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 423

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 376

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 355

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 126

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 253

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 313

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 271

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 342

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Viatris Launches Cash Tender Offers for Outstanding Notes

Updated Category News Views 56

Viatris Launches Cash Tender Offers for Outstanding Notes Viatris Inc. (NASDAQ: VTRS), a leading player in the global healthcare sector, has initiated tender offers to acquire certain outstanding notes. This move is designed to strengthen its financial framework and enhance returns for its shareholders. Notably, the offers include various senior notes that were originally...

Continue Reading
Coke Florida Launches Joyful Holiday Caravan Across Florida

Updated Category News Views 239

Coke Florida Kicks Off Holiday Spirit with Caravan Tour Coca-Cola Beverages Florida, LLC (Coke Florida) is thrilled to share that its beloved annual "Holiday Caravan" is set to return. This event, which has become an essential part of the holiday season, features the iconic Coca-Cola red delivery truck decked out in festive cheer. Families will enjoy complimentary samples...

Continue Reading
Nexxen to Join RBC Conference, Share Insights on Technology

Updated Category News Views 68

Nexxen's Upcoming Participation at RBC Global Conference Nexxen International Ltd. (AIM/NASDAQ: NEXN), a leading global advertising technology platform, is geared up to take part in a significant event, the RBC Global Technology, Internet, Media and Telecommunications Conference. This event provides a stellar opportunity for companies to connect with investors and share...

Continue Reading
GayVeterans.us Obtains 501(c)(3) Status to Broaden Support

Updated Category News Views 125

GayVeterans.us Achieves 501(c)(3) Tax Exempt Status GayVeteransUS-Inc. has recently been granted 501(c)(3) tax-exempt status, marking a significant milestone for the organization. This designation enables supporters to make tax-deductible contributions, strengthening the community's ability to provide enhanced resources and support. The dedication of veteran volunteers...

Continue Reading
Virbac Expands Portfolio with Acquisition of Felanorm Solution

Updated Category News Views 130

Virbac Enhances Its Offerings with Felanorm Acquisition Virbac has announced a significant acquisition that marks a pivotal moment in its commitment to improving the health and quality of life for senior cats. This globally recognized drug is aimed at treating feline hyperthyroidism, a condition that is becoming increasingly common in older cats. Understanding Feline...

Continue Reading